Home › Amgen pays $290M to exit osteoporosis drug deal
 

Keywords :   


Amgen pays $290M to exit osteoporosis drug deal

2014-04-04 06:17:49| Biotech - Topix.net

Amgen will pay $290 million to end its collaboration with British drugmaker GlaxoSmithKline to commercialize the osteoporosis drug denosumab in certain markets outside the U.S. Amgen will pay $290 million to end its collaboration with British drugmaker GlaxoSmithKline to commercialize the osteoporosis drug denosumab in certain markets outside the ... (more)

Tags: deal pays drug exit

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Graphics
07.07Tropical Storm Beryl Forecast Discussion Number 36
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
07.07Tropical Storm Beryl Public Advisory Number 35A
07.07Summary for Tropical Storm Beryl (AT2/AL022024)
More »